Skip to content

A clinical trial to study the effects of two different dressings, honey dressing and betadine dressing in patients with diabetic foot ulcer

Clinico Microbiological efficacy of Honey Dressing in comparison with Povidone Iodine Dressing on Diabetic Foot Ulcers: a Randomized Controlled Clinical Trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2015/01/005457
Enrollment
80
Registered
2015-01-23
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- DIABETIC FOOT ULCER PATIENTS

Interventions

Intervention1: honey dressing: honey dressing upto 6 weeks applied topically Control Intervention1: Povidone iodin: Povidone iodine dressing upto 6 week applied topically

Sponsors

Manipal university
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient voluntarily willing to participate and give written informed consent, to comply with all study requirements Patient with Known or newly diagnosed diabetes mellitus confirmed by ADA 2013 criteria Patients with non healing ulcer of Wagner Classification grade 1 and 2 for atleast 2 weeks Patients willing to follow up and complete treatment Patient who does not require frequent debridement.( frequent debridement is defined as >1 debridement a ulcer per week )

Exclusion criteria

Exclusion criteria: Acute wound less than 2 weeks duration. Patients with ulcer (Wagner classification 3,4 and 5 Patient with cellulitis or abscess. Fasting plasma glucose, more than 240mg/dl at the time of recruitment Renal disease needing hemodialysis or transplantation Hepatic disease with elevated transaminases > 2.5 times the upper limit of normal or bilirubin > 2 mg/dl congestive cardiac failure with NYHA class III and IV Patient with active MRSA, VRE, Streptococcal infection. Patients on i.v antibiotics

Design outcomes

Primary

MeasureTime frame
PERCENTAGE REDUCTION IN ULCER SIZE AFTER 6 WEEKS OF DRESSINGTimepoint: 6week

Secondary

MeasureTime frame
â?¢ Incidence of adverse events â?¢ Proportion of participants with completely healed wound â?¢ Proportion of participants with Microbiological clearance. â?¢ Incidence of super infection â?¢ Length of hospital stay â?¢ Time of appearance of healthy granulated tissue â?¢ Number of debridement required â?¢ Effect on exudate and malador Timepoint: baseline and then every week upto 6 week

Countries

India

Contacts

Public ContactDrPrabha adhikari

Department Of Medicine, Kasturba Medical College, Mangalore, Manipal University

prabha.raghuveer@gmail.com9880991290

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 8, 2026